遺伝性非ポリポーシス大腸癌
□記事を途中から表示しています
[最初から表示]
^ Bellizzi AM, Frankel WL (2009). “Colorectal cancer due to deficiency in DNA mismatch repair function: a review”. Advances in Anatomic Pathology 16 (6): 405?417. doi:10.1097/PAP.0b013e3181bb6bdc. PMID 19851131.
^ Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR (November 2005). ⇒“Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability”. Arch. Pathol. Lab. Med. 129 (11): 1390?7. PMID 16253017. ⇒http://journals.allenpress.com/jrnlserv/?request=get-abstract&issn=0003-9985&volume=129&page=1390.
^ Umar A, Boland CR, Terdiman JP, et al. (February 2004). ⇒“Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability”. J. Natl. Cancer Inst. 96 (4): 261?8. PMID 14970275. ⇒http://jnci.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=14970275.
^ Lipton LR, Johnson V, Cummings C, et al. (December 2004). ⇒“Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic”. J. Clin. Oncol. 22 (24): 4934?43. doi:10.1200/JCO.2004.11.084. PMID 15611508. ⇒http://www.jco.org/cgi/pmidlookup?view=long&pmid=15611508.
^ Winawer SJ. "Heredity and family history - How to draw your family tree. The benefits of genetic screening-". Cancer Free: the Comprehensive Cancer Prevention Program. 1996;46-67
^ Warthin AS. Heredity with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the university of Michigan 1895-1913. Arch Intern Med 1913;12:546-55
^ Vasen HF, et al. Guideline fo the clinical management of Lynch syndrome(hereditary non-polyposis cancer). J Med Gnet 2007;44:353-62
^ ⇒http://jsft.umin.jp/hp/msikensa.html
^ ⇒Pathology of Hereditary Nonpolyposis Colorectal Cancer - JASS 910 (1): 62 - Annals of the New York Academy of Sciences
^ ⇒http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim
^ Fishel R, Lescoe M, Rao M, Copeland N, Jenkins N, Garber J, Kane M, Kolodner R (1993). “The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer”. Cell 75 (5): 1027?38. doi:10.1016/0092-8674(93)90546-3. PMID 8252616.
^ Papadopoulos N, Nicolaides N, Wei Y, Ruben S, Carter K, Rosen C, Haseltine W, Fleischmann R, Fraser C, Adams M (1994). “Mutation of a mutL homolog in hereditary colon cancer”. Science 263 (5153): 1625?9. doi:10.1126/science.8128251. PMID 8128251.
^ Thompson E, Meldrum CJ, Crooks R, et al. (March 2004). ⇒“Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations”. Clin. Genet. 65 (3): 215?25. doi:10.1111/j.1399-0004.2004.00214.x. PMID 14756672. ⇒http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0009-9163&date=2004&volume=65&issue=3&spage=215.
^ ⇒http://grj.umin.jp/grj/hnpcc.htm
^ Nicolaides NC, Papadopoulos N, Liu B, et al. (September 1994). “Mutations of two PMS homologues in hereditary nonpolyposis colon cancer”. Nature 371 (6492): 75?80. doi:10.1038/371075a0. PMID 8072530.
^ Lu SL, Kawabata M, Imamura T, et al. (May 1998). “HNPCC associated with germline mutation in the TGF-beta type II receptor gene”. Nat. Genet. 19 (1): 17?8. doi:10.1038/ng0598-17. PMID 9590282.
^ Ou J, Rasmussen M, Westers H, et al. (April 2009). “Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome”. Genes Chromosomes Cancer 48 (4): 340?50. doi:10.1002/gcc.20644. PMID 19156873.
^ Ramsoekh D, Wagner A, van Leerdam ME, et al. (November 2008). ⇒“A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting”. Gut 57 (11): 1539?44. doi:10.1136/gut.2008.156695. PMID 18625694. ⇒http://gut.bmj.com/cgi/pmidlookup?view=long&pmid=18625694.
次ページ記事の検索おまかせリスト▼オプションを表示暇つぶしWikipedia
Size:46 KB
出典: フリー百科事典『ウィキペディア（Wikipedia）』
担当:undef